🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate safety and immunogenicity of Pedia...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00343421
Treatments Being Tested
The purpose of the study is to provide immunogenicity and safety data of th...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00401531
This study aims to investigate the effects of aP booster vaccination in chi...
Status
Completed
Location
University of Turku
Start Date
2018-04-18
Trial ID
NCT03697798
Treatments Being Tested
The goal of this observational study is to learn about vaccine immunity in ...
Status
Recruiting
Location
University Hospital Bern
Start Date
2023-11-14
Trial ID
NCT06333275
Infection with human papillomavirus (HPV) has been clearly established as t...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-02-13
Trial ID
NCT00426361
Treatments Being Tested
The purpose of the study is to provide data on the safety and immunogenicit...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00355654
Treatments Being Tested
The objective for this study is to characterize the safety profile of PENTA...
Status
Completed
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT00804284
Treatments Being Tested
The Bacille Calmette-Guérin (BCG) vaccine is the only vaccine licenced to p...
Status
Completed
Location
University of Oxford, Oxford Vaccine Group
Start Date
2014-06-20
Trial ID
NCT02002156
The overall aim of the study is to corroborate that a schedule consisting o...
Status
Completed
Location
Multiple Locations
Start Date
2005-11
Trial ID
NCT00255047
Pediacel™ is currently licensed in the UK for use as a 3 dose regimen for t...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00287092
Treatments Being Tested